abstract |
The present invention provides compounds of formula (Ia) or (Ib): formula (Ia) or (Ib), or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all Variables are as defined in this application. These compounds are selective LPA receptor inhibitors. |